Compare AGRO & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGRO | PAHC |
|---|---|---|
| Founded | 2002 | 1946 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2011 | 2014 |
| Metric | AGRO | PAHC |
|---|---|---|
| Price | $11.78 | $35.83 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 4 |
| Target Price | $12.80 | ★ $41.25 |
| AVG Volume (30 Days) | ★ 966.8K | 202.0K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.43% | 0.91% |
| EPS Growth | N/A | ★ 104.20 |
| EPS | N/A | ★ 2.43 |
| Revenue | N/A | ★ $833,350,000.00 |
| Revenue This Year | $45.90 | $17.03 |
| Revenue Next Year | N/A | $3.82 |
| P/E Ratio | $37.52 | ★ $15.14 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $6.89 | $28.25 |
| 52 Week High | $15.89 | $60.08 |
| Indicator | AGRO | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 69.53 | 51.17 |
| Support Level | $12.04 | $36.31 |
| Resistance Level | $13.86 | $37.92 |
| Average True Range (ATR) | 0.47 | 1.58 |
| MACD | 0.16 | -0.06 |
| Stochastic Oscillator | 86.70 | 28.10 |
Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.